Route 92 Medical Raises Over $31 Million in Oversubscribed Series F Equity Financing to Accelerate its Commercialization into the Rapidly Growing Stroke Treatment Market
16 nov. 2023 09h00 HE | Route 92 Medical, Inc.
Route 92 Medical raises over $31 million in oversubscribed Series F equity financing to accelerate its commercialization.
Route 92 Medical Announces Impressive Clinical Results for its Tenzing® Technology.
14 nov. 2023 09h00 HE | Route 92 Medical, Inc.
Multicenter clinical study results published in Stroke: Vascular and Interventional Neurology show benefits of Route 92 Medical's Tenzing technology.
Emergen logo.png
Global Urgent Care Apps Market Size USD 42,960.91 Million in 2032 | Emergen Research
07 nov. 2023 14h00 HE | Emergen Research
Vancouver, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The global urgent care apps market is projected to reach value of USD 42,960.91 Million by 2032, according to a current analysis by Emergen Research....
Neurovascular Devices Market - Global Forecast to 2028: Increasing Incidence of Ischemic Stroke and Cerebral Aneurysms Boosts Demand
18 oct. 2023 05h48 HE | Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Neurovascular Devices Market by Disease Pathology (Cerebral Ameurysm (Embolic coils), Ischemic Stroke (Clot retrievers, Aspiration, Microcatheters),...
Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress
10 oct. 2023 08h00 HE | electroCore, Inc.
“VANQUISH” Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache Associated with Subarachnoid Hemorrhage (SAH) “NOVIS” Clinical Trial (n=150) of nVNS for the...
Aviv-Clinic Logo.png
Aviv Clinics Highlights Case Report Showing Hyperbaric Oxygen Therapy Improves Post-Stroke Rehabilitation, Specifically Hand Motor Recovery
02 oct. 2023 13h04 HE | Aviv Clinics
ORLANDO, Fla., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Aviv Clinics, one of the world’s most advanced brain clinics, shares the results of a new case report showing a unique hyperbaric oxygen therapy...
Company logo.png
A Special Protocol Assessment Agreement Reached with the U.S. Food and Drug Administration for Phase 3 clinical trial of Sovateltide for the treatment of acute cerebral ischemic stroke patients
02 oct. 2023 07h25 HE | Pharmazz, Inc.
Special Protocol Assessment Agreement Reached Between Pharmazz, Inc. and the U.S. Food and Drug Administration for Phase 3 Clinical Trial of Sovateltide
Company logo.png
Pharmazz Inc. and Sun Pharma enter into licensing agreement for introducing Tyvalzi™ (Sovateltide) in India
14 sept. 2023 00h30 HE | Pharmazz, Inc.
Sovateltide is a first of its kind drug to treat acute cerebral ischemic stroke that can be administered up to 24 hours after the onset of symptomsIndia is the first global territory where Tyvalzi™...
Global Stroke Care Continuum Research Report 2023: Trends, Growth Opportunities, and Forecasts 2023-2027 with 2022 as the Base Year
04 août 2023 09h33 HE | Research and Markets
Dublin, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Stroke Care Continuum: Trends, Growth Opportunities, and Forecasts" report has been added to ResearchAndMarkets.com's offering. This study...
Neurocritical AI solution to be deployed into A&E at Milton Keynes University Hospital NHS Foundation Trust
01 août 2023 03h15 HE | Blackford
EDINBURGH, Scotland, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Blackford, the pioneering strategic AI platform and solutions provider, has partnered with Qure.ai, a leading provider of artificial...